Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Woolworths (ASX: WOW) outbids Wesfarmers (ASX: WES) for control of Australian Pharmaceutical (ASX:API)

The Wesfarmers (ASX: WES) and Woolworths (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical (ASX: API). 

The Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API).

Previously, Wesfarmers had made a binding offer of $1.55 per share for the pharmacy chain, which had been recommended by the API board.

The deal looked largely complete until today’s shock announcement.

Wesfarmers and Woolworths were formerly fierce competitors in the supermarket sector before Wesfarmer’s spun off Coles Group Ltd (ASX: COL) in 2018.

Battle for API heats up

Woolworths $1.75 per share cash offer via a scheme of arrangement values the Priceline Pharmacy chain owner at $872 million.

It’s a 20 cents per share or a 12.9% premium to Wesfarmers $1.55 per share proposal on November 8.

Woolworths’s bid is still subject to due diligence, which it believes will take four weeks.

On that timeline, a binding offer would be expected by mid-January 2022.

Woolworths deal is subject to regulatory approval, a unanimous recommendation by the API board and an Independent Expert concluding the bid is in shareholders best interests.

Wesfarmers still holds the ace

Woolworths audacious bid for API still has one critical hurdle to jump through.

Wesfarmers bought a 19.3% stake in API, therefore it holds a substantial share of voting power against any other proposal, including Woolworths.

Subsequently, Woolworths would need to convince the remaining 80.7% of API’s shareholders to vote in its favour.

A scheme of arrangement requires at least 75% of shareholder votes. Therefore, the supermarket giant would need at least 92% of API’s shareholders on its side should Wesfarmers vote against the deal – no easy task.

Woolworths has said it’s open to exploring alternative control structures, such as a takeover bid with acceptance of just 50.1%.

Nonetheless, Wesfarmers won’t roll over easily given it’s already fended off a competing offer from Sigma Healthcare Ltd (ASX: SIG).

The conglomerate has the right to match Woolworths bid, which would make for a fierce standoff.

API response

The API board has allowed Woolworths to undertake due diligence as it believes the offer is superior to Wesfarmers:

“…the API Board considers that the Woolworths Proposal is reasonably capable of being valued, implemented and completed in accordance with its terms, and, if completed substantially in accordance with its terms, be more favourable to API shareholders as a whole than the Wesfarmers Scheme”

My take

In what is generally a quiet month for corporate Australia, Woolworths, Wesfarmers and its bankers will be working feverishly to win control for API.

I’d expect Wesfarmers to match the bid, and then force Woolworths to other raise or walk away.

Either way, the battle for API looks to be heating up again.

To keep up to date on all the latest news regarding the API takeover, be sure to bookmark the Rask Media home page.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content